Evogene Ltd. - צמיחת הכנסות שנתית ב-12 החודשים האחרונים EVGN

Evogene Ltd. (EVGN) minimizes risks by integrating computational biology into medicine and the agricultural sector. The 12-month year-over-year revenue change history on the GURU.Markets terminal chart confirms this trend, where the -80.80 level serves as a critical benchmark. Its status as a scientific authority in genome optimization and the trust global partners place in the precision of its AI algorithms solidify the brand's leadership.
פילוחי נתונים אנליטיים מרוכזים עבור evogene.com (EVGN)

Effective asset selection requires balancing business expansion rates against the risks of valuation corrections. The TTM annual revenue growth rate measures the percentage change in sales over a rolling 12-month period, smoothing out quarterly volatility. For Evogene Ltd. (EVGN), a leader in computational biology and AI, this metric reflects the commercialization of innovative seeds. The trend in the TTM annual revenue growth rate signals the actual market adoption of the company's technologies.